During the past decade, Institut für Pneumologie an der Universität zu Köln / Wissenschaftliches Institut Bethanien für Pneumologie e.V. conducted 15 clinical trials. In the 10-year time frame, 15 clinical trials started and 3 clinical trials were completed, i.e. on average, 20% percent of trials that started reached the finish line to date. In the past 5 years, 5 clinical trials started and 3 clinical trials were completed. i.e. 60% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Institut für Pneumologie an der Universität zu Köln / Wissenschaftliches Institut Bethanien für Pneumologie e.V." #1 sponsor was "Wissenschaftliches Institut Bethanien e.V" with 11 trials, followed by "Boehringer Ingelheim" with 3 trials sponsored, "Heinen und Löwenstein GmbH & Co. KG" with 1 trials sponsored, "Lungpacer Medical Inc." with 1 trials sponsored and "Philips Respironics" with 1 trials sponsored. Other sponsors include -4 different institutions and companies that sponsored additional 6 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Institut für Pneumologie an der Universität zu Köln / Wissenschaftliches Institut Bethanien für Pneumologie e.V." #1 collaborator was "Philips Respironics" with 3 trials as a collaborator, "Boehringer Ingelheim" with 1 trials as a collaborator, "Canadian Institutes of Health Research (CIHR)" with 1 trials as a collaborator, "Institute of Pathology, University Clinic Düsseldorf" with 1 trials as a collaborator and "Merck Sharp & Dohme LLC" with 1 trials as a collaborator. Other collaborators include -4 different institutions and companies that were collaborators in the rest 6 trials.

According to Clinical.Site data, the most researched conditions in "Institut für Pneumologie an der Universität zu Köln / Wissenschaftliches Institut Bethanien für Pneumologie e.V." are "COVID-19" (3 trials), "Heart Failure" (2 trials), "Idiopathic Pulmonary Fibrosis" (2 trials), "Lung Diseases, Interstitial" (2 trials) and "Obstructive Sleep Apnea" (2 trials). Many other conditions were trialed in "Institut für Pneumologie an der Universität zu Köln / Wissenschaftliches Institut Bethanien für Pneumologie e.V." in a lesser frequency.

Most popular intervention types in "Institut für Pneumologie an der Universität zu Köln / Wissenschaftliches Institut Bethanien für Pneumologie e.V." are "Device" (5 trials), "Diagnostic Test" (4 trials), "Drug" (3 trials) and "Procedure" (1 trials). Other intervention types were less common.

The name of intervention was led by "Nintedanib" (3 trials), "Placebo" (2 trials), "Adaptive Servo Ventilation" (1 trials), "Bi-Level-APAP treatment with subsequent CPAP treatment" (1 trials) and "COVID-19 nasal/pharyngeal swab" (1 trials). Other intervention names were less common.

The vast majority of trials in "Institut für Pneumologie an der Universität zu Köln / Wissenschaftliches Institut Bethanien für Pneumologie e.V." are 18 trials for "All" genders.

Currently, there are NaN active trials in "Institut für Pneumologie an der Universität zu Köln / Wissenschaftliches Institut Bethanien für Pneumologie e.V.". undefined are not yet recruiting, 1 are recruiting, 2 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 12 completed trials in Institut für Pneumologie an der Universität zu Köln / Wissenschaftliches Institut Bethanien für Pneumologie e.V., undefined suspended trials, and 1 terminated clinical trials to date.

Out of the total trials that were conducted in Institut für Pneumologie an der Universität zu Köln / Wissenschaftliches Institut Bethanien für Pneumologie e.V., 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 2 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 4 trials that are defined as “Not Applicable".